
APDN Announces Pricing of $4.2 Million Registered Direct Offering
February 22nd, 2022
APDN Announces Pricing of $4.2 Million Registered Direct Offering
February 22nd, 2022
APDN FQ1’22 Financial Results Feature Record Quarterly Revenues
February 10th, 2022
APDN Schedules FQ1’22 Financial Results Call and Webcast
February 3rd, 2022
APDN Reports 4th Quarter and Full Fiscal Year 2021 Financial Results
December 9th, 2021
APDN Schedules Q4 and Full FY’21 Financial Results Call and Webcast
December 3rd, 2021
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
September 7th, 2021
FQ3’2021 Revenues Increased 294% Year-Over-Year to $1.7 Million
August 12th, 2021
Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
August 5th, 2021
FQ2’21 Financial Results Feature 384% Year-Over-Year Growth in Revenues
May 13th, 2021